Hrt Financial LP Bio Xcel Therapeutics, Inc. Transaction History

Hrt Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$1.14 - $2.97 $60,431 - $157,439	53,010 New	53,010 $67,000
Q3 2023 Nov 13, 2023	BUY	$2.49 - $11.85 $180,031 - $856,778	72,302 New	72,302 $182,000
Q2 2022 Aug 12, 2022	BUY	$9.03 - $21.55 $363,890 - $868,421	40,298 New	40,298 $531,000
Q3 2021 Nov 15, 2021	SELL	$23.84 - $32.03 $1.27 Million - $1.7 Million	-53,138 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$29.06 - $38.83 $1.29 Million - $1.72 Million	44,394 Added 507.71%	53,138 $1.54 Million
Q1 2021 May 17, 2021	BUY	$39.04 - $64.6 $341,365 - $564,862	8,744 New	8,744 $377,000

3.12M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $9.25M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.